Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M104,107Revenue (TTM) $M36,852Net Margin (%)2.5Altman Z-Score1.3
Enterprise Value $M126,364EPS (TTM) $0.4Operating Margin %7.5Piotroski F-Score4
P/E(ttm)112Beneish M-Score-2.6Pre-tax Margin (%)4.7Higher ROA y-yN
Price/Book25.210-y EBITDA Growth Rate %0.3Quick Ratio0.8Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %-5.1Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow131y-y EBITDA Growth Rate %-73.8ROA % (ttm)1.1Higher Current Ratio y-yN
Dividend Yield %5.5PEG--ROE % (ttm)11.1Less Shares Outstanding y-yN
Payout Ratio %635Shares Outstanding M2,435ROIC % (ttm)7.7Gross Margin Increase y-yN

Gurus Latest Trades with GSK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GSKHOTCHKIS & WILEY 2016-03-31 Reduce-0.52%$38.54 - $42.05
($39.84)
$ 42.757%Reduce -26.34%8,915,323
GSKKahn Brothers 2016-03-31 Add0.36%$38.54 - $42.05
($39.84)
$ 42.757%Add 55.97%131,950
GSKCharles Brandes 2016-03-31 Add0.1%$38.54 - $42.05
($39.84)
$ 42.757%Add 3.98%4,474,409
GSKJohn Rogers 2016-03-31 Add0.05%$38.54 - $42.05
($39.84)
$ 42.757%Add 7.17%1,582,913
GSKNWQ Managers 2016-03-31 Add0.02%$38.54 - $42.05
($39.84)
$ 42.757%Add 6.02%498,115
GSKTweedy Browne 2016-03-31 Reduce-0.02%$38.54 - $42.05
($39.84)
$ 42.757%Reduce -12.81%116,070
GSKKen Fisher 2016-03-31 Add0.01%$38.54 - $42.05
($39.84)
$ 42.757%Add 1.09%11,657,855
GSKJoel Greenblatt 2016-03-31 Reduce$38.54 - $42.05
($39.84)
$ 42.757%Reduce -1.24%51,331
GSKBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Add$38.54 - $42.05
($39.84)
$ 42.757%Add 1.12%251,800
GSKDodge & Cox 2016-03-31 Reduce$38.54 - $42.05
($39.84)
$ 42.757%Reduce -27.95%81,262
GSKCharles Brandes 2015-12-31 Reduce-0.21%$39.1 - $43.53
($40.81)
$ 42.755%Reduce -7.92%4,303,030
GSKKahn Brothers 2015-12-31 Add0.2%$39.1 - $43.53
($40.81)
$ 42.755%Add 47.13%84,600
GSKHOTCHKIS & WILEY 2015-12-31 Reduce-0.05%$39.1 - $43.53
($40.81)
$ 42.755%Reduce -2.40%12,102,919
GSKJohn Rogers 2015-12-31 Add0.01%$39.1 - $43.53
($40.81)
$ 42.755%Add 1.29%1,476,976
GSKKen Fisher 2015-12-31 Add$39.1 - $43.53
($40.81)
$ 42.755%Add 0.03%11,531,673
GSKTweedy Browne 2015-12-31 Reduce$39.1 - $43.53
($40.81)
$ 42.755%Reduce -0.25%133,124
GSKNWQ Managers 2015-12-31 Add$39.1 - $43.53
($40.81)
$ 42.755%Add 1.68%469,830
GSKDodge & Cox 2015-12-31 Reduce$39.1 - $43.53
($40.81)
$ 42.755%Reduce -44.42%112,782
GSKJoel Greenblatt 2015-12-31 Add$39.1 - $43.53
($40.81)
$ 42.755%Add 1.01%51,973
GSKDodge & Cox 2015-09-30 Reduce-0.46%$37.56 - $45.14
($41.64)
$ 42.753%Reduce -98.37%202,915
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GSK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$2295.86view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.14103.83view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29714.56view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12259.08view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14207.79view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12259.08view

Press Releases about GSK :

Quarterly/Annual Reports about GSK:

    News about GSK:

    Articles On GuruFocus.com
    PhaseRX: The Latest Pick From a Legendary VC Firm May 24 2016 
    Kahn Brothers Adds to BP, GlaxoSmithKline Stakes May 10 2016 
    A Closer Look Into Veritas Pharma Apr 21 2016 
    Dividend and Value Opportunities in the Large-Cap Pharmaceutical Space Apr 05 2016 
    Why the UK Is Headed For a Slowdown Mar 23 2016 
    Insiders Roundup: Theravance Biopharma, Western Gas, Upland Software Mar 18 2016 
    Brandes Makes a Variety of Reductions in 4th Quarter Feb 11 2016 
    10 Fund Managers Are Totally Wrong on GlaxoSmithKline Jan 26 2016 
    Stocks Bring High Dividend Yields to HOTCHKIS & WILEY Jan 14 2016 
    Jeff Auxier's Holdings Trading Below Peter Lynch Earnings Line Jan 04 2016 

    More From Other Websites
    Lloyds Banking Group plc vs GlaxoSmithKline plc: which is the better growth stock? May 27 2016
    There has never been a better time to buy GlaxoSmithKline plc, Persimmon plc and Admiral Group plc May 27 2016
    Ionis Hits 3-Year Low As GlaxoSmithKline Drops Big Trial Plans May 26 2016
    Ionis shares plummet as GSK scraps heart drug trial plans May 26 2016
    [$$] Ionis's Shares Fall After Co-Developer Opts Against Starting Late-Stage Trial May 26 2016
    Why Ionis Pharmaceuticals (IONS) Stock Is Tanking Today May 26 2016
    Ionis Pharmaceuticals Inc (IONS) Plunges After GSK Foregos Phase 3 Study of TTRRx May 26 2016
    Glaxo/Innoviva Report Positive COPD Data on Relvar Ellipta May 25 2016
    Could the Worlds Most Effective Quit Smoking Aid be a Low Nicotine Cigarette US Public Health... May 25 2016
    6:20 am GlaxoSmithKline, Fondazione Telethon, & Ospedale San Raffaele announce publication in BLOOD... May 25 2016
    GSK, Fondazione Telethon and Ospedale San Raffaele announce publication of pivotal safety and... May 25 2016
    Is GlaxoSmithKline plc a better dividend buy than Standard Life plc and Legal & General Group plc? May 25 2016
    Why this GSK news is good for workers in Zebulon May 24 2016
    GSK lung drug succeeds in big UK study, after earlier miss May 24 2016
    GSK lung drug succeeds in big UK study, after earlier miss May 24 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)